Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Papillary Thyroid Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06440850
What this trial is testing

Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E Mutation

Who this might be right for
Thyroid Gland Follicular CarcinomaThyroid Gland Oncocytic CarcinomaThyroid Gland Papillary Carcinoma
City of Hope Medical Center 21
Not applicableStudy completedNCT04197960
What this trial is testing

Microwave Ablation and Surgical Resection for Micropapillary Thyroid Carcinoma

Who this might be right for
Papillary Thyroid Carcinoma
Chinese PLA General Hospital 973
Testing effectiveness (Phase 2)Ended earlyNCT03506048
What this trial is testing

Lenvatinib and Iodine Therapy in Treating Patients With Radioactive Iodine-Sensitive Differentiated Thyroid Cancer

Who this might be right for
Differentiated Thyroid Gland CarcinomaThyroid Gland Follicular CarcinomaThyroid Gland Papillary Carcinoma
Emory University 4
Testing effectiveness (Phase 2)Active Not RecruitingNCT02650401
What this trial is testing

Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options

Who this might be right for
Solid TumorsCNS Tumors
Hoffmann-La Roche 69
Not applicableStudy completedNCT02178345
What this trial is testing

Predictive MRI Metrics for Tumor Aggressiveness in Papillary Thyroid Cancer

Who this might be right for
Papillary Thyroid Cancer
Memorial Sloan Kettering Cancer Center 123
Not applicableActive Not RecruitingNCT02776969
What this trial is testing

A Gene Hunting Study for Familial Papillary Thyroid Cancer

Who this might be right for
Thyroid
Ohio State University Comprehensive Cancer Center 1,200
Testing effectiveness (Phase 2)UnknownNCT05675605
What this trial is testing

TY-1091 in Patients With Advanced Solid Tumors

Who this might be right for
RET-altered Non Small Cell Lung CancerMedullary Thyroid CancerRET-altered Papillary Thyroid Cancer+1 more
TYK Medicines, Inc 248
Large-scale testing (Phase 3)Looking for participantsNCT06791005
What this trial is testing

A Clinical Study on the Benefits of Carbon Nanoparticles Injection Time in Patients With Thyroid Cancer.

Who this might be right for
Papillary Thyroid Cancer
Second Affiliated Hospital of Xi'an Jiaotong University 400
Not applicableWithdrawnNCT02726282
What this trial is testing

Impact of Papillary Microcarcinoma Terminology on Patients Treatment Preferences: a Cross Sectional Survey

Who this might be right for
Thyroid Cancer
Mayo Clinic
Testing effectiveness (Phase 2)Study completedNCT00389441
What this trial is testing

Study Of AG-013736 In Patients With 131I-Refractory Thyroid Cancer

Who this might be right for
Thyroid Neoplasms
Pfizer 52
Not applicableActive Not RecruitingNCT02938702
What this trial is testing

Active Surveillance on Papillary Thyroid Microcarcinoma

Who this might be right for
Thyroid CancerPapillary Thyroid Microcarcinoma
Seoul National University Hospital 1,211
Early research (Phase 1)Ended earlyNCT03469011
What this trial is testing

Try to Bring Back Radioiodine Sensitivity in Patients With Advanced Thyroid Cancer.

Who this might be right for
Papillary Thyroid Cancer
AHS Cancer Control Alberta 14
Not applicableNot Yet RecruitingNCT07584447
What this trial is testing

Clinical Utility of Preoperative Thyroid GuidePx® Testing

Who this might be right for
Papillary Thyroid CancerPapillary Thyroid Carcinoma
University of Calgary 85
Not applicableLooking for participantsNCT06725576
What this trial is testing

Ultrasound-Guided Microwave Ablation Vs. Surgery for Low-Risk PapilaryThyroid Carcinoma

Who this might be right for
Thyroid Cancer, Papillary
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 201
Not applicableStudy completedNCT04594720
What this trial is testing

Circulating Biomarkers to Identify Thyroid Cancer

Who this might be right for
Thyroid CancerThyroid Cancer, PapillaryBenign Thyroid Tumor
Chang Gung Memorial Hospital 100
Not applicableLooking for participantsNCT00001160
What this trial is testing

Studies on Tumors of the Thyroid

Who this might be right for
Hurthle Cell Thyroid CancerTall Cell Variant Thyroid CancerFollicular Thyroid Cancer+2 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2,500
Not applicableLooking for participantsNCT05575440
What this trial is testing

Evaluation of 18F-TFB PET/CT Scan in Patients With Differentiated Thyroid Cancer

Who this might be right for
Differentiated Thyroid Gland CarcinomaThyroid Gland Follicular CarcinomaThyroid Gland Papillary Carcinoma
Mayo Clinic 24
Early research (Phase 1)WithdrawnNCT00937417
What this trial is testing

S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerHead and Neck CancerLung Cancer+2 more
SWOG Cancer Research Network
Testing effectiveness (Phase 2)Study completedNCT01025453
What this trial is testing

Combination of Temsirolimus and Sorafenib in the Treatment of Radioactive Iodine Refractory Thyroid Cancer

Who this might be right for
Thyroid Cancer
Memorial Sloan Kettering Cancer Center 37
Early research (Phase 1)Ended earlyNCT02313012
What this trial is testing

Safety and PK Study of CC-90003 in Relapsed/Refractory Solid Tumors

Who this might be right for
Neoplasm Metastasis
Celgene 19
Next Page